Search Results - "Murphy, Kathryn L."
-
1
Identification of the Critical Residues of Bradykinin Receptor B1 for Interaction with the Kinins Guided by Site-Directed Mutagenesis and Molecular Modeling
Published in Biochemistry (Easton) (05-12-2006)“…We report the critical residues for the interaction of the kinins with human bradykinin receptor 1 (B1) using site-directed mutagenesis in conjunction with…”
Get full text
Journal Article -
2
Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1
Published in Biochemical and biophysical research communications (27-05-2005)“…We report the first homology model of human bradykinin receptor B1 generated from the crystal structure of bovine rhodopsin as a template. Using an automated…”
Get full text
Journal Article -
3
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model
Published in The Journal of pharmacology and experimental therapeutics (01-08-2004)“…Antagonists of the B1 bradykinin receptor (B1R) offer the promise of novel therapeutic agents for the treatment of inflammatory and neuropathic pain. However,…”
Get more information
Journal Article -
4
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist
Published in European journal of pharmacology (19-09-2004)“…Compound A (N-[2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethyl]-2-[(2R)-1-(2-napthylsulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]acetamide) is a member of…”
Get full text
Journal Article -
5
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist
Published in Life sciences (1973) (01-03-1996)“…L-744,453 ((±)3-[4-(1-carboxy-1-(3,4-methylenedioxyphenyl)methoxy)-3,5-dipropylphenylmethyl]-3H-imidazo[4,5- c]pyridine) is an endothelin (ET) receptor…”
Get full text
Journal Article -
6
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B 1 receptor antagonist
Published in European journal of pharmacology (19-09-2004)“…Compound A ( N-{2-[4-(4,5-dihydro-1 H-imidazol-2-yl)phenyl]ethyl}-2-[(2 R)-1-(2-napthylsulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]acetamide) is a member…”
Get full text
Journal Article -
7
Potent dual antagonists of endothelin and angiotensin II receptors derived from α-phenoxyphenylacetic acids (Part III)
Published in Bioorganic & medicinal chemistry letters (08-06-1995)“…Screening a collection of α-phenoxyphenylacetic acid derived angiotensin II antagonists identified weak actives in an endothelin receptor binding assay…”
Get full text
Journal Article